PMC:7784829 / 513-639
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"23","span":{"begin":6,"end":37},"obj":"Gene"},{"id":"24","span":{"begin":39,"end":43},"obj":"Gene"}],"attributes":[{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Gene:59272"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Gene:59272"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ptor, angiotensin converting enzyme 2 (ACE2). Targeting entry of the virus has a better advantage than inhibiting the later st"}